XIPERE

Drug Bausch & Lomb Americas Inc.
Total Payments
$1.1M
Transactions
4,431
Doctors
1,574
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $175,710 1,083 573
2023 $227,362 1,369 747
2022 $559,433 1,827 872
2021 $78,460 122 73
2020 $37,217 30 16

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $624,256 298 57.9%
Compensation for serving as faculty or as a speaker for a medical education program $224,086 237 20.8%
Food and Beverage $134,424 3,751 12.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $63,518 15 5.9%
Travel and Lodging $28,105 106 2.6%
Space rental or facility fees (teaching hospital only) $3,500 1 0.3%
Education $291.87 23 0.0%

Top Doctors Receiving Payments for XIPERE — Page 3

Doctor Specialty Location Total Records
Marlene Azar Detroit, MI $3,574 5
, MD Specialist Boston, MA $3,413 4
, MD Ophthalmology Los Angeles, CA $3,396 4
, M.D Retina Specialist Annapolis, MD $3,162 14
, M.D Ophthalmology Hagerstown, MD $2,951 24
, M.D Ophthalmology Baltimore, MD $2,469 3
, MD Ophthalmology Cleveland, OH $2,360 15
, M.D Retina Specialist Portsmouth, VA $2,308 12
, MD Ophthalmology Chicago, IL $2,268 3
, M.D Ophthalmology Tampa, FL $2,195 11
, M.D. MSC Student in an Organized Health Care Education/Training Program Sacramento, CA $1,920 10
, M.D Ophthalmology Durham, NC $1,771 6
, MD Retina Specialist Saint Louis, MO $1,593 6
, MD Ophthalmology Royal Oak, MI $1,559 2
, MD Ophthalmology Long Beach, CA $1,545 3
, M.D Ophthalmology Waltham, MA $1,531 2
, M.D Ophthalmology Arlington, TX $1,500 1
, MD Ophthalmology Baltimore, MD $1,500 1
, MD Ophthalmology Stanford, CA $1,394 5
, M.D., M.S Ophthalmology Manassas, VA $1,143 8
, M.D Retina Specialist Royal Oak, MI $1,140 21
, MD Retina Specialist Milwaukee, WI $1,117 2
, MD Ophthalmology Harvey, IL $1,109 5
, MD Ophthalmology Los Angeles, CA $1,076 4
, MD Retina Specialist Harvey, IL $1,041 9

About XIPERE

XIPERE is a drug associated with $1.1M in payments to 1,574 healthcare providers, recorded across 4,431 transactions in the CMS Open Payments database. The primary manufacturer is Bausch & Lomb Americas Inc..

Payment data is available from 2020 to 2024. In 2024, $175,710 was paid across 1,083 transactions to 573 doctors.

The most common payment nature for XIPERE is "Consulting Fee" ($624,256, 57.9% of total).